San Diego biotech Cidara Therapeutics just raised an impressive $42 million Series B round – with plans to speed up development of its antifungal and immunotherapy drugs, and bring them to clinical trial later this year. The startup has two antifungal programs underway – called Biafungin and Topifungin. Biafungin is meant to be a once-weekly intravenous […]
Cidara Therapeutics has emerged from relative obscurity with a new name, a new antifungal drug platform and a $32 million Series A financing round to help bring it to clinical trial over the next 18 months. The financing will help Cidara advance candidates from its Cloudbreak targeted immunotherapy platform, and bring its novel antifungal drug […]
Choosing the right brain injury rehabilitation program is a critical decision that can shape the future for you or your loved one.